Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Why Alembic Pharma Is A Great Stock To Buy Even Now



Alembic Pharma has a great run on the stock exchange with a 181% YOY return. However, given its’ high ROE, size of opportunity and reasonable valuations, there is still a lot of scope for gain in the stock says Meeta Shetty, CFA, of HDFC Securities




meeta_shetty_HDFC

Alembic Pharma is “Gearing for a leap” says Meeta Shetty of HDFC Securities in her initiating coverage report. Meeta Shetty has given convincing reasons that in view of the high CAGR of revenue, high ROE/ROCE of 40% +, the consistent free cash flows and high margin product opportunities, there is still great opportunity for gain in Alembic Pharma.

Click here to download HDFC Sec’s Alembic Pharma Research Report
investments, Mid Cap, Multibagger, Portfolio, stock picker   

3 Comments
  1. jalil inamdar's Gravatar jalil inamdar
    March 23, 2014 at 12:14 pm | Permalink

    I want buy alembice fharma. Its right price. I want hold 10 years

    Reply
  2. Kalyan's Gravatar Kalyan
    March 23, 2014 at 4:50 pm | Permalink

    It has really run up and after this report, it will go up even further, in the immediate short run. Is it worth the risk?

    Reply
    • Kalyan's Gravatar Kalyan
      March 29, 2014 at 6:06 pm | Permalink

      I have added a decent quantity, inspite of my caution above. So far, it had looked good and I made use (to enter) of 1 day when it crashed 6%

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 508 other subscribers

RSS Stocks Talk Forum

  • Saurabh Mukherjea has shuffled his PMS portfolios
    Saurabh Mukherjea has shuffled his PMS portfolios. Bajaj Finserv & CMS Info are added to the Kings of Capital portfolio. Ahluwalia Contracts is added to Rising Giants portfolio while Clean Science is added to Little Champs. Eureka Forbes is exited as there is intense competition ... Saurabh Mukherjea has shuffled his PMS portfolios
  • Anant Raj is riding India's data center wave. TP ₹1100 (31%)
    Anant Raj is riding India's data center wave. Multiple growth levers are at play. Strong pre-sales, collections & operational cash flows underpin its growth. Significant revenue, EBITDA margin expansion & long-term value creation expected. TP ₹1100 (31%) Download research report... Anant Raj is riding India's data center wave. TP ₹1100 (31%)
  • Mukul Agrawal's portfolio has 56 stocks valued at ₹7,329 Cr in Dec'24 (vs ₹4,695 Cr in 2023, up +56%
    Mukul Agrawal's portfolio has 56 stocks valued at ₹7,329 Cr in Dec'24 (vs ₹4,695 Cr in 2023, up +56%). 6 stocks ASM, Hind Rectifier, Neuland, LT Foods, Pearl Global & Concord are multibaggers with 100%+ YoY gain. Other big YoY winners are Raghav (97%), PTC (95%) & Nuvama (91%) ... Mukul Agrawal's portfolio has 56 […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!